BLIS Technologies (NZSE:BLT) Pre-Tax Income : NZ$0.70 Mil (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. BLIS Technologies's pretax income for the six months ended in Mar. 2024 was NZ$1.37 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.70 Mil. BLIS Technologies's pretax margin was 22.07%.

During the past 13 years, BLIS Technologies's highest Pretax Margin was 15.34%. The lowest was -54.42%. And the median was -6.97%.

BLIS Technologies Pre-Tax Income Historical Data

The historical data trend for BLIS Technologies's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies Pre-Tax Income Chart

BLIS Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Pre-Tax Income

Get a 7-Day Free Trial

1.60

0.56

-2.71

-1.35

0.70

BLIS Technologies Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															-0.91	-1.69	0.34	-0.67	1.37

Competitive Comparison of BLIS Technologies's Pre-Tax Income

For the Biotechnology subindustry, BLIS Technologies's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BLIS Technologies's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BLIS Technologies's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where BLIS Technologies's Pre-Tax Income falls into.

BLIS Technologies Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

BLIS Technologies's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.29	+	1.084	+	-0.031	+	0.405	+	0.528
	=	0.70

BLIS Technologies's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	0.308	+	0.601	+	-0.014	+	0.207	+	0.264
	=	1.37

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.70 Mil.

BLIS Technologies (NZSE:BLT) Pre-Tax Income Explanation

BLIS Technologies's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	1.366	/	6.19
	=	22.07%

During the past 13 years, BLIS Technologies's highest Pretax Margin was 15.34%. The lowest was -54.42%. And the median was -6.97%.

BLIS Technologies Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

BLIS Technologies (NZSE:BLT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016

Website

https://www.blis.co.nz

BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets two strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 both of which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).